NIH unit awards $6.5M grant to Dana-Farber for vaccine research

08/15/2010 | Mass High Tech (Boston)

The National Institute of Allergy and Infectious Diseases, a division of the NIH, has awarded a $6.5 million grant to Dana-Farber Cancer Institute to help it develop a universal T cell-based vaccine against influenza A viruses. "Our ultimate goal is a vaccine that targets the conserved viral segments that cannot vary from one viral strain to another, thereby providing protection against all seasonal and pandemic flus," said Ellis Reinherz, the study's principal investigator.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC